Receptor-Interacting Serine-threonine Kinase 2 (RIPK2) (Middle Region) Peptide
RIPK2
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5512448
Quick Overview for Receptor-Interacting Serine-threonine Kinase 2 (RIPK2) (Middle Region) Peptide (ABIN5512448)
Target
RIPK2
(Receptor-Interacting Serine-threonine Kinase 2 (RIPK2))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequence
- SLNIPVNHGP QEESCGSSQL HENSGSPETS RSLPAPQDND FLSRKAQDCY
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- RIPK2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- RIPK2 (Receptor-Interacting Serine-threonine Kinase 2 (RIPK2))
-
Background
-
This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein contains a C-terminal caspase activation and recruitment domain (CARD), and is a component of signaling complexes in both the innate and adaptive immune pathways. It is a potent activator of NF-kappaB and inducer of apoptosis in response to various stimuli.
Alias Symbols: CCK, RICK, RIP2, CARD3, GIG30, CARDIAK
Protein Size: 540 -
Gene ID
- 8767
-
NCBI Accession
- NM_003821, NP_003812
-
UniProt
- O43353
Target
-
You are here:
